G
Greenwich LifeSciences, Inc. (GLSI)
NCM – Real Time Price. Currency in USD
16.90
+1.35 (8.68%)
At close: Aug 12, 2026, 3:59 PM EDT
16.95
+0.03 (0.18%)
After-hours: Aug 12, 2026, 4:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
16.90
+1.35 (8.68%)
At close: Aug 12, 2026, 3:59 PM EDT
16.95
+0.03 (0.18%)
After-hours: Aug 12, 2026, 4:38 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $10.5M barely cover the upcoming debt maturities $0.0
Total current assets $10.5M exceed Total current liabilities $5.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.01 | 6.05 | 10 | |
| Quick ratio | 2.01 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -4K | -4K | -4K | -2K | -876 |
| Operating Income | -8M | -9M | -18M | -19M | -22M |
| Net Income | -8M | -9M | -17M | -19M | -22M |
| EBITDA | -8M | -9M | -18M | -19M | -22M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -10 | 1.0 |
| Next quarter | N/A | -1.52 | 1.0 |
| Current year | N/A | -13.06 | 1.0 |
| Next year | N/A | 15.52 | 5.0 |
| Weighted average score | 2.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 28.6 | -15.62 | -48.12 | 5.5 |
| Y/Y | 999 | -106.1 | -47.99 | -156.33 | 3.3 |
| 3y average | 999 | -40.19 | -29.88 | -17.67 | 3.3 |
| 5y average | 999 | -67.42 | -47.78 | -73.93 | 3.3 |
| Weighted average score | 3.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |